US Patent 11517584 RNAi agents for Hepatitis B virus infection
Patent 11517584 was granted and assigned to Arrowhead Pharmaceuticals, Inc. on December, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11517584 RNAi agents for Hepatitis B virus infection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.